在动脉样硬化中使用CRISPR技术准循环RNA (circRNAs)
Areej Nazarudeen1, V A Aswathy2, Arun A Rauf1
1Department of Biochemistry, University of Kerala, Thiruvananthapuram, Kerala, India.
The journal of gene medicine
|November 11, 2025
概括
循环RNA (circRNAs) 和CRISPR基因编辑显示出治疗动脉样硬化的前景. 研究突出了针对心血管疾病的新型治疗策略的特定circRNAs和CRISPR-Cas系统.
科学领域:
- 心血管研究研究心血管研究
- 分子生物学分子生物学
- 基因编辑技术 基因编辑技术
背景情况:
- 动脉样硬化是心血管疾病的主要原因,由慢性炎症驱动.
- 循环RNAs (circRNAs) 调节炎症,脂质代谢和与动脉样硬化相关的斑块稳定性的关键过程.
- 特定的circRNA如circANRIL,circHIPK和circRSF1都与动脉样硬化发展有关.
研究的目的:
- 在动脉样硬化中审查circRNAs的生物发生和功能.
- 探索CRISPR-Cas技术 (Cas9和Cas13) 在研究和潜在治疗动脉样硬化的应用.
- 讨论基于circRNA的疗法和CRISPR-Cas13治疗动脉样硬化的潜力.
主要方法:
- 在动脉样硬化研究中审查关于circRNAs和CRISPR-Cas技术的现有文献.
- 分析特定的circRNAs (circANRIL,circHIPK,circRSF1) 和它们的作用.
- 检查CRISPR-Cas9用于脂质代谢的修饰和CRISPR-Cas13用于RNA级干预的应用.
主要成果:
- CRISPR-Cas9使得PCSK9,LDLR和APOB等向基因能够调节脂质代谢,并在动脉样硬化模型中治疗诸如家族性高胆固醇血症等疾病.
- CRISPR-Cas13为选择性circRNA编辑提供了一种新的RNA向策略,以调节与动脉样硬化相关的途径.
- 特定的circRNAs显著影响动脉样硬化进展和发展.
结论:
- 循环RNA研究和CRISPR创新在动脉样硬化治疗方面具有革命性的潜力.
- 需要进一步的研究来阐明circRNA机制,并开发有效的CRISPR-Cas13传递系统.
- 广泛的临床前验证对于将这些发现转化为心血管疾病的临床应用至关重要.
相关概念视频
02:15Experimental RNAi
7.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.2K
01:59CRISPR
57.4K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
57.4K
02:53CRISPR and crRNAs
18.7K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
18.7K
01:28CRISPR/Cas9 Genome Editing
1.6K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
1.6K
02:30siRNA - Small Interfering RNAs
18.3K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.3K